Inogen (INGN) Total Current Liabilities (2013 - 2026)
Inogen (INGN) posted quarterly Total Current Liabilities of $61.4 million for Q1 2026, down 6.12% year-over-year from $65.5 million in Q1 2025, and down 3.29% quarter-over-quarter from $63.5 million in Q4 2025.
Inogen (INGN) Total Current Liabilities (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Total Current Liabilities for 14 consecutive years, with $61.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 6.12% year-over-year to $61.4 million; the TTM figure through Mar 2026 stood at $61.4 million (down 6.12% YoY), while the FY2025 annual figure was $63.5 million, down 17.15% from the prior year.
- Total Current Liabilities eased to $61.4 million in Q1 2026 per INGN's latest filing, from $63.5 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $76.7 million in Q4 2024 and bottomed at $59.3 million in Q2 2022.
- Historically, Total Current Liabilities has averaged $66.1 million across 5 years, with a median of $65.3 million in 2022.
- Annual changes were most pronounced in 2024 — Total Current Liabilities climbed 21.59% — and 2025, when it retreated 17.15%.
- Inogen's Total Current Liabilities stood at $65.3 million in 2022, then climbed by 10.94% to $72.5 million in 2023, then rose by 5.78% to $76.7 million in 2024, then retreated by 17.15% to $63.5 million in 2025, then fell by 3.29% to $61.4 million in 2026.
- Business Quant data shows INGN's Total Current Liabilities at $61.4 million in Q1 2026, $63.5 million in Q4 2025, and $64.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Inogen | 151.72 Mn | 46.18 Mn | 43.27 Mn | 70.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 70.86 Mn |
| Mar 31, 2026 | 61.45 Mn |
| Dec 31, 2025 | 63.54 Mn |
| Sep 30, 2025 | 64.94 Mn |
| Jun 30, 2025 | 67.07 Mn |
| Mar 31, 2025 | 65.45 Mn |
| Dec 31, 2024 | 76.69 Mn |
| Sep 30, 2024 | 72.40 Mn |
| Jun 30, 2024 | 72.19 Mn |
| Mar 31, 2024 | 73.91 Mn |
| Dec 31, 2023 | 72.50 Mn |
| Sep 30, 2023 | 60.38 Mn |
| Jun 30, 2023 | 59.37 Mn |
| Mar 31, 2023 | 63.38 Mn |
| Dec 31, 2022 | 65.35 Mn |
| Sep 30, 2022 | 65.74 Mn |
| Jun 30, 2022 | 59.34 Mn |
| Mar 31, 2022 | 59.82 Mn |
| Dec 31, 2021 | 61.51 Mn |
| Sep 30, 2021 | 59.93 Mn |